That is very important, because the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (social media). Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was an advancement almost nobody observed. But it's going to have extensive ramifications for curing disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment chances in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (genetic sequencer stock jeff brown). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back possibly considerably prior to going greater - democratic republic. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. first lady. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous great private companies on the brink of striking the general public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the information. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers know that tech isn't our normal beat (jeff brown investment prediction). And when it pertains to tech investing, we leave it to the professionals. Thankfully, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (democratic republic). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and producing incredible chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown. However despite what many readers might believe, this is a trend that's just getting begun. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown genetic sequencing stock). Losing two months of production and sales actually affects how lots of 5G gadgets are sold in the calendar year. When you consider all of that, offering 250 million systems is impressive. More importantly, the delays triggered by the pandemic produced a lots of bottled-up demand. And that demand is now going to be pressed into 2021. In fact, I anticipate that more than 500 million 5G devices will be shipped in 2021 - brownstone research. Which's not my only 5G forecast When I have actually talked about 5G in the past, I've explained its three various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Phase 3, 5G services begin to be provided (legacy report prediction). That's when we start to see applications operating on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of people don't actually appreciate the innovation. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next crucial technology I anticipate in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually just 3 business running in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation just works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This whole industry is effectively a greenfield chance.
There's room for many companies to exist in this area. brownstone research stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can precisely predict the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is essential due to the fact that the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug treatments produced using this innovation. This was among those developments that almost no one observed. But it's going to have extensive implications for treating disease. And, naturally, there will be lots of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back possibly considerably before going greater. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin - jeff brown stock market prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. jeff brown genome sequencing stock. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we might not separately validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an exceptional perspective on the marketplace. He's constantly on the hunt for new chances, and he shares a lot of his best choices in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted some of the greatest financial occasions of the previous twenty years. Although he does not appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it ideal whenever, but Jeff Brown's precise predictions have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research study offers a number of research services with a variety of expertises - united arab emirates.
The company is also affiliated with Bonner & Partners, another well-respected research study publisher - jeff brown 2020 predictions. On its site, Brownstone says its objective is to provide retail financiers with professional-grade research: "For too long, the finest investment research has actually not been offered to specific financiers. It has actually been usually booked for financial investment banks, hedge funds, personal equity, and high-net-worth customers. brownstone research. The objective of Brownstone Research is to make that sort of proprietary research study available to any investors looking to get an edge in the marketplaces. The goal is basic to provide special and rewarding investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. diplomatic relations. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown believes S.A.V. tech stock. might be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: synthetic intelligence and electric cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the automobile market's Holy Grail. As you understand, electrical vehicles and self-driving automobile stocks have been substantial this year, but the Wall Street device has approved buzz without much concrete outcome. Despite an extreme boost in competitors over the past couple of years, Brown still thinks Musk has the finest chance of putting it all together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would permit you to lease your automobile as a self-governing, self-driving taxi when you're not using it. You just get out of the automobile and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the earnings. It sounds ridiculous, however it might be closed than you believe.